IN8bio, Inc.(INAB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

INAB IN8bio, Inc.

盘后交易 07-22 16:18:12 EDT

0.8726

+0.0426

+5.13%

最高0.8900	最低0.8361	成交量9.53万
今开0.8400	昨收0.8300	日振幅6.49%
总市值3,850万	流通市值1,950万	总股本4,412万
成交额8.25万	换手率0.43%	流通股本2,235万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"INAB","market":"US","secType":"STK","nameCN":"IN8bio, Inc.","latestPrice":0.8726,"timestamp":1721678400000,"preClose":0.83,"halted":0,"volume":95328,"delay":0,"floatShares":22350862,"shares":44123949,"eps":-0.899731,"marketStatus":"盘后交易","marketStatusCode":4,"change":0.0426,"latestTime":"07-22 16:18:12 EDT","open":0.84,"high":0.89,"low":0.8361,"amount":82510.492637,"amplitude":0.06494,"askPrice":0.875,"askSize":5602,"bidPrice":0.841,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.899731,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1721692800000},"adr":0,"listingDate":1605157200000,"adjPreClose":0.83,"preHourTrading":{"tag":"盘前","latestPrice":0.835,"preClose":0.83,"latestTime":"07:51 EDT","volume":357,"amount":298.09499999999997,"timestamp":1721649087127},"volumeRatio":1.098694},"requestUrl":"/m/hq/s/INAB/wiki","defaultTab":"wiki","newsList":[{"id":"2453713770","title":"In8Bio, Inc.盘中异动 下午盘股价大涨5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453713770","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453713770?lang=zh_cn&edition=full","pubTime":"2024-07-23 01:08","pubTimestamp":1721668126,"startTime":"0","endTime":"0","summary":"北京时间2024年07月23日01时08分，In8Bio, Inc.股票出现异动，股价快速拉升5.24%。截至发稿，该股报0.874美元/股，成交量4.5797万股，换手率0.10%，振幅3.98%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723010847aefacdd8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723010847aefacdd8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INAB","BK4539"],"gpt_icon":0},{"id":"2450253340","title":"In8Bio, Inc.盘中异动 快速上涨6.86%报0.898美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450253340","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450253340?lang=zh_cn&edition=full","pubTime":"2024-07-12 21:31","pubTimestamp":1720791086,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日21时31分，In8Bio, Inc.股票出现异动，股价急速拉升6.86%。截至发稿，该股报0.898美元/股，成交量5839股，换手率0.01%，振幅0.87%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407122131269f3c00b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407122131269f3c00b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","INAB","BK4139"],"gpt_icon":0},{"id":"2448161179","title":"In8Bio, Inc.盘中异动 股价大跌5.92%报0.765美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448161179","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448161179?lang=zh_cn&edition=full","pubTime":"2024-07-03 00:27","pubTimestamp":1719937643,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日00时27分，In8Bio, Inc.股票出现异动，股价快速跳水5.92%。截至发稿，该股报0.765美元/股，成交量9.5042万股，换手率0.22%，振幅9.59%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.67%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703002723af903757&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703002723af903757&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INAB","BK4539"],"gpt_icon":0},{"id":"2448994668","title":"In8Bio, Inc.盘中异动 大幅下挫5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448994668","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448994668?lang=zh_cn&edition=full","pubTime":"2024-07-02 01:50","pubTimestamp":1719856236,"startTime":"0","endTime":"0","summary":"北京时间2024年07月02日01时50分，In8Bio, Inc.股票出现异动，股价快速下挫5.49%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.65%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702015036aef770fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702015036aef770fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","INAB","BK4139"],"gpt_icon":0},{"id":"2445077939","title":"In8Bio, Inc.盘中异动 早盘股价大涨5.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2445077939","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445077939?lang=zh_cn&edition=full","pubTime":"2024-06-24 21:50","pubTimestamp":1719237056,"startTime":"0","endTime":"0","summary":"北京时间2024年06月24日21时50分，In8Bio, Inc.股票出现波动，股价快速上涨5.68%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.81%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624215056941f0934&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624215056941f0934&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","INAB"],"gpt_icon":0},{"id":"2444217855","title":"In8Bio, Inc.盘中异动 快速跳水5.00%报0.950美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444217855","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444217855?lang=zh_cn&edition=full","pubTime":"2024-06-20 21:46","pubTimestamp":1718891206,"startTime":"0","endTime":"0","summary":"北京时间2024年06月20日21时46分，In8Bio, Inc.股票出现异动，股价快速下挫5.00%。截至发稿，该股报0.950美元/股，成交量12.1197万股，换手率0.27%，振幅2.00%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620214646aef5dac2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620214646aef5dac2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","INAB"],"gpt_icon":0},{"id":"2444160420","title":"In8Bio, Inc.盘中异动 快速拉升5.05%报1.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444160420","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444160420?lang=zh_cn&edition=full","pubTime":"2024-06-17 21:36","pubTimestamp":1718631411,"startTime":"0","endTime":"0","summary":"北京时间2024年06月17日21时36分，In8Bio, Inc.股票出现波动，股价快速拉升5.05%。截至发稿，该股报1.15美元/股，成交量17.5077万股，换手率0.40%，振幅2.75%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061721365296814a05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061721365296814a05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INAB","BK4539"],"gpt_icon":0},{"id":"2443673555","title":"In8Bio, Inc.盘中异动 早盘快速下跌10.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443673555","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443673555?lang=zh_cn&edition=full","pubTime":"2024-06-14 21:31","pubTimestamp":1718371861,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日21时31分，In8Bio, Inc.股票出现波动，股价大幅跳水10.71%。截至发稿，该股报1.50美元/股，成交量23.3551万股，换手率0.53%，振幅0.00%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406142131019f3d3662&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406142131019f3d3662&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INAB","BK4539","LGVN"],"gpt_icon":0},{"id":"2442527035","title":"In8Bio, Inc.盘中异动 股价大跌5.48%报1.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442527035","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442527035?lang=zh_cn&edition=full","pubTime":"2024-06-12 21:30","pubTimestamp":1718199050,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日21时30分，In8Bio, Inc.股票出现波动，股价快速跳水5.48%。截至发稿，该股报1.32美元/股，成交量5350股，换手率0.01%，振幅0.00%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061221305096813ae1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061221305096813ae1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","INAB","BK4139"],"gpt_icon":0},{"id":"2442806313","title":"In8Bio, Inc.盘中异动 大幅拉升5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442806313","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442806313?lang=zh_cn&edition=full","pubTime":"2024-06-11 22:53","pubTimestamp":1718117637,"startTime":"0","endTime":"0","summary":"北京时间2024年06月11日22时53分，In8Bio, Inc.股票出现异动，股价急速拉升5.34%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.27%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611225358aef45dbd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611225358aef45dbd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4139","BK4539"],"gpt_icon":0},{"id":"2442184216","title":"In8Bio, Inc.盘中异动 急速上涨7.39%报1.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442184216","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442184216?lang=zh_cn&edition=full","pubTime":"2024-06-10 21:32","pubTimestamp":1718026331,"startTime":"0","endTime":"0","summary":"北京时间2024年06月10日21时32分，In8Bio, Inc.股票出现异动，股价大幅上涨7.39%。截至发稿，该股报1.44美元/股，成交量13.1131万股，换手率0.30%，振幅3.73%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.49%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406102132119f2ccaf5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406102132119f2ccaf5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4539","BK4139"],"gpt_icon":0},{"id":"2440360192","title":"In8Bio, Inc.盘中异动 早盘股价大涨7.34%报1.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2440360192","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440360192?lang=zh_cn&edition=full","pubTime":"2024-06-04 21:56","pubTimestamp":1717509407,"startTime":"0","endTime":"0","summary":"北京时间2024年06月04日21时56分，In8Bio, Inc.股票出现波动，股价急速拉升7.34%。截至发稿，该股报1.17美元/股，成交量2.2757万股，换手率0.05%，振幅2.75%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604215647af8bef0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604215647af8bef0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANNX","BK4539","INAB","BK4139"],"gpt_icon":0},{"id":"2440495723","title":"In8Bio, Inc.盘中异动 早盘大幅下跌7.56%报1.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2440495723","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440495723?lang=zh_cn&edition=full","pubTime":"2024-06-03 21:32","pubTimestamp":1717421568,"startTime":"0","endTime":"0","summary":"北京时间2024年06月03日21时32分，In8Bio, Inc.股票出现波动，股价急速下跌7.56%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603213248aef30cf6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603213248aef30cf6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","BK4539","BK4139"],"gpt_icon":0},{"id":"2439990257","title":"In8Bio, Inc.盘中异动 早盘急速上涨8.74%报1.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439990257","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439990257?lang=zh_cn&edition=full","pubTime":"2024-05-31 21:57","pubTimestamp":1717163848,"startTime":"0","endTime":"0","summary":"北京时间2024年05月31日21时57分，In8Bio, Inc.股票出现波动，股价快速拉升8.74%。截至发稿，该股报1.12美元/股，成交量1.8595万股，换手率0.04%，振幅3.87%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.25%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240531215729aef2cde8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240531215729aef2cde8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","INAB"],"gpt_icon":0},{"id":"2437794295","title":"In8Bio, Inc.盘中异动 早盘大幅上涨5.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2437794295","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437794295?lang=zh_cn&edition=full","pubTime":"2024-05-22 21:46","pubTimestamp":1716385589,"startTime":"0","endTime":"0","summary":"北京时间2024年05月22日21时46分，In8Bio, Inc.股票出现异动，股价快速拉升5.94%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522214629861ee5ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522214629861ee5ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INAB","BK4539"],"gpt_icon":0},{"id":"2435034758","title":"HC Wainwright & Co.：维持IN8bio(INAB.US)评级，由买入调整至买入评级, 目标价由14.00美元调整至12.50美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2435034758","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435034758?lang=zh_cn&edition=full","pubTime":"2024-05-13 17:45","pubTimestamp":1715593528,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：维持IN8bio(INAB.US)评级，由买入调整至买入评级, 目标价由14.00美元调整至12.50美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405131745298b00e754&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405131745298b00e754&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB"],"gpt_icon":0},{"id":"2431951598","title":"In8Bio, Inc.盘中异动 股价大跌5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431951598","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431951598?lang=zh_cn&edition=full","pubTime":"2024-04-29 23:13","pubTimestamp":1714403598,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日23时13分，In8Bio, Inc.股票出现异动，股价大幅下挫5.58%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.86%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化用于固体和液体肿瘤的γ-δ T细胞产品候选药，采用同种异体、自体和基因改良的γ-δ T细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240429231318861ea21b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240429231318861ea21b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","INAB","BK4139"],"gpt_icon":0},{"id":"2429119898","title":"In8Bio, Inc.盘中异动 早盘急速下挫5.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429119898","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429119898?lang=zh_cn&edition=full","pubTime":"2024-04-23 23:02","pubTimestamp":1713884577,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日23时02分，In8Bio, Inc.股票出现波动，股价急速下挫5.99%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.51%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于通过使用同种异体、自体和基因修饰的 gamma-delta T 细胞，发现、开发和商业化用于实体和液体肿瘤的 gamma-delta T 细胞候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232302577922b4b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232302577922b4b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","INAB","BK4139"],"gpt_icon":0},{"id":"2428585660","title":"In8Bio, Inc.盘中异动 股价大跌5.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428585660","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2428585660?lang=zh_cn&edition=full","pubTime":"2024-04-20 02:15","pubTimestamp":1713550536,"startTime":"0","endTime":"0","summary":"北京时间2024年04月20日02时15分，In8Bio, Inc.股票出现异动，股价大幅下跌5.71%。截至发稿，该股报0.990美元/股，成交量15.6554万股，换手率0.36%，振幅6.67%。In8Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。In8Bio, Inc.公司简介：IN8bio Inc 是一家临床阶段的生物制药公司，专注于通过使用同种异体、自体和基因修饰的 gamma-delta T 细胞，发现、开发和商业化用于实体和液体肿瘤的 gamma-delta T 细胞候选产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404200215367921ec45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404200215367921ec45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INAB","BK4539"],"gpt_icon":0},{"id":"2427009050","title":"In8Bio, Inc.盘中异动 快速下跌5.26%报1.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427009050","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2427009050?lang=zh_cn&edition=full","pubTime":"2024-04-15 21:52","pubTimestamp":1713189135,"startTime":"0","endTime":"0","summary":"北京时间2024年04月15日21时52分，In8Bio, Inc.股票出现波动，股价大幅下跌5.26%。截至发稿，该股报1.05美元/股，成交量3.4681万股，换手率0.08%，振幅1.80%。In8Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.95%。其相关个股中，安皮奥制药、Soligenix, Inc.、Longeveron Inc.涨幅较大，Longeveron Inc.、Allarity Therapeutics, Inc.、Soligenix, Inc.较为活跃，换手率分别为796.40%、695.07%、690.87%，振幅较大的相关个股有Soligenix, Inc.、Cassava Sciences Inc C/Wts 15/11/2024、Longeveron Inc.，振幅分别为79.05%、75.77%、74.56%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404152152167920a117&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404152152167920a117&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INAB","LGVN","BK4539","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.in8bio.com","stockEarnings":[{"period":"1week","weight":-0.0545},{"period":"1month","weight":-0.17},{"period":"3month","weight":-0.1942},{"period":"6month","weight":-0.3806},{"period":"1year","weight":-0.4813},{"period":"ytd","weight":-0.3986}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"In8bio, Inc.于2016年2月8日在百慕大注册成立。2018年5月7日，该公司在一项交易中重新并入美国，在该交易中，该公司转变为一家新成立的特拉华州公司，该公司是一家临床阶段生物技术公司，专注于通过使用同种异体、自体和基因修饰的γ-δT细胞。γ-δT细胞是人体免疫系统中自然产生的细胞，它识别并杀死癌细胞，同时具有保护健康组织的肿瘤识别机制。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.098793},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.077829},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.098136},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.097265},{"month":5,"riseRate":0.666667,"avgChangeRate":0.389911},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.253166},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.043121},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.136828},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.074083},{"month":10,"riseRate":0.333333,"avgChangeRate":0.005196},{"month":11,"riseRate":0,"avgChangeRate":-0.162866},{"month":12,"riseRate":0.666667,"avgChangeRate":0.246461}],"exchange":"NASDAQ","name":"IN8bio, Inc.","nameEN":"IN8bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"IN8bio, Inc.(INAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供IN8bio, Inc.(INAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"IN8bio, Inc.,INAB,IN8bio, Inc.股票,IN8bio, Inc.股票老虎,IN8bio, Inc.股票老虎国际,IN8bio, Inc.行情,IN8bio, Inc.股票行情,IN8bio, Inc.股价,IN8bio, Inc.股市,IN8bio, Inc.股票价格,IN8bio, Inc.股票交易,IN8bio, Inc.股票购买,IN8bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"IN8bio, Inc.(INAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供IN8bio, Inc.(INAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}